Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.24.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenue $ 18,279 $ 12,912
Cost of revenue 9,200 6,698
Gross profit 9,079 6,214
Operating expenses:    
Sales and marketing 8,472 7,157
Research and development 5,025 3,626
General and administrative 10,694 10,987
Total operating expenses 24,191 21,770
Loss from operations (15,112) (15,556)
Other (expense) income, net:    
Interest expense, net (302) (156)
(Loss) gain on revaluation of warrant liabilities (133) 1,317
Unrealized gain (loss) on foreign exchange 412 (655)
Other expense, net (63) (30)
Total other (expense) income, net (86) 476
Net loss (15,198) (15,080)
Foreign currency translation adjustments (407) 580
Comprehensive loss $ (15,605) $ (14,500)
Net loss per share applicable to common shareholders, basic and diluted (in dollars per share) $ (1.1) $ (1.16)
Weighted average number of shares outstanding, basic and diluted (in shares) 13,867 12,962